Exin Therapeutics' CEO Says an AI Agent Picked the Gene Therapy and Brain Coordinates for a Mouse Surgery, Then Wouldn't Let Him Override It
Gabriel Ocana-Santero says his startup's agent chose an epilepsy treatment from 19 candidates, steered a motorized rig to inject it into a mouse's brain, and refused to retry a blocked move even when he pushed it to.
By Chris PirilloRead the story























